Key result
Smokeless tobacco use was significantly associated with an increased risk of myocardial infarction (OR 2.341) and cerebrovascular accidents (OR 3.771) compared to non-users.
Why the study?
The study was conducted to determine the independent prognostic significance of smokeless tobacco products on disease outcomes such as myocardial infarction and stroke.
Does smokeless tobacco use increase the risk of myocardial infarction and stroke in patients with suspected coronary artery disease and stroke?
Observational (n=423)
No
Does smokeless tobacco use increase the risk of myocardial infarction and stroke in patients with suspected coronary artery disease and stroke?
Odds Ratio: 2.341 (95% CI 1.1–5.4)
p-value: p=0.041
Smokeless tobacco use is associated with an increased risk of myocardial infarction and stroke in patients presenting with suspected cardiovascular disease.
SLT use was associated with higher MI and stroke incidence; leaves open independent prognostic value pending larger confirmatory studies.
Background: The use of smokeless tobacco (SLT) predates smoking and its effects on the health of the individuals is very much similar tobacco smoking. The present study was done with the aim to find out independent prognostic significance of ST products on disease outcome like myocardial infarction and stroke.Methods: This prospective study was done on the patients attending to the Department of Internal Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar with complaints suggesting of coronary artery disease and stroke during the period from July 2016 to June 2018. The exposure of risk factors and confounding factors are detailed and collected from the patients by using predesigned questionnaire. All the data was analysed by using SPSS version 20.Results: During the study period a total of 423 patients were included in the study. Mean average age of the participants was 56.58±11.23 years. Male preponderance was seen in the study. Out of total patients, myocardial infarction was noticed in 49 and stroke in 64 patients. SLT was used by 323 (76.4%) users. Among SLT both gutkha and pan was most commonly used (55.6%). Among them hypertension and diabetes were seen in 193 and 184 patients respectively. Risk of incidence of CVA and stroke was found to be more among SLT users compared to non-users.Conclusions: SLT is considered to be an important etiological factor for the incidence of myocardial infarction and stroke. There is an urgent need to increase clinical interventions and awareness in public to decrease SLT addiction.
No takes yet. Share an insight, caveat, or question.
Behera et al. (2019) conducted an observational in Coronary artery disease and stroke (n=423). Smokeless tobacco vs. Non-users was evaluated on Myocardial infarction (OR 2.341, 95% CI 1.10-5.40, p=0.041). Smokeless tobacco use was significantly associated with an increased risk of myocardial infarction (OR 2.341) and cerebrovascular accidents (OR 3.771) compared to non-users.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: